Elanco Animal Health (ELAN)
(Delayed Data from NYSE)
$13.79 USD
+0.11 (0.80%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $13.80 +0.01 (0.07%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth A Momentum C VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
ELAN 13.79 +0.11(0.80%)
Will ELAN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ELAN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ELAN
Can Phosphate Binders Drive DaVita Stock Before Q2 Earnings?
ELAN vs. USPH: Which Stock Is the Better Value Option?
ELAN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Are Medical Stocks Lagging Encompass Health (EHC) This Year?
Are Options Traders Betting on a Big Move in ELAN Stock?
What Makes Elanco Animal Health (ELAN) a New Buy Stock
Other News for ELAN
EU Approval Boosts Elanco (ELAN) with Zenrelia Milestone | ELAN Stock News
Elanco announces European Commission approval of Zenrelia
Elanco (ELAN) Sees Price Target Increase to $18 by UBS | ELAN Stock News